作者
Jessica E Ellerman, Charles K Brown, Michael De Vera, Herbert J Zeh, Timothy Billiar, Anna Rubartelli, Michael T Lotze
发表日期
2007/5/15
来源
Clinical Cancer Research
卷号
13
期号
10
页码范围
2836-2848
出版商
American Association for Cancer Research
简介
Since its identification a third of a century ago, the high-mobility group box-1 (HMGB1) protein has been linked to varied diverse cellular processes, including release from necrotic cells and secretion by activated macrophages engulfing apoptotic cells. Initially described as solely chromatin-associated, HMGB1 was additionally discovered in the cytoplasm of several types of cultured mammalian cells 6 years later. In addition to its intracellular role, HMGB1 has been identified extracellularly as a putative leaderless cytokine and differentiation factor. In the years since its discovery, HMGB1 has also been implicated in disease states, including Alzheimer's, sepsis, ischemia-reperfusion, arthritis, and cancer. In cancer, overexpression of HMGB1, particularly in conjunction with its receptor for advanced glycation end products, has been associated with the proliferation and metastasis of many tumor types, including …
引用总数
200720082009201020112012201320142015201620172018201920202021202220232024626303536474749393728282215151883
学术搜索中的文章
JE Ellerman, CK Brown, M De Vera, HJ Zeh, T Billiar… - Clinical Cancer Research, 2007